Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan

NCT04133987 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

OTHER

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: Tetravalent live attenuated dengue vaccine admixture TV005
BIOLOGICAL: Placebo

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]